NCT06113458

Brief Summary

The goal of this clinical trial is to compare the effectiveness of evidence-based, adapted, and tailored, patient-focused and clinic-focused strategies to improve blood pressure (BP) control in English- and Spanish-speaking patients with hypertension (HTN).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,500

participants targeted

Target at P75+ for not_applicable hypertension

Timeline
26mo left

Started Oct 2024

Longer than P75 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Oct 2024Jul 2028

First Submitted

Initial submission to the registry

October 27, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 2, 2023

Completed
12 months until next milestone

Study Start

First participant enrolled

October 21, 2024

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2028

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2028

Last Updated

January 23, 2026

Status Verified

January 1, 2026

Enrollment Period

3.4 years

First QC Date

October 27, 2023

Last Update Submit

January 21, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in systolic BP (clinic)

    Clinic-based BP readings in EHR

    Baseline, 6 months

Secondary Outcomes (5)

  • Change in systolic BP (home)

    Baseline, 6 months

  • Patient activation and satisfaction

    Baseline, 6 months

  • Number of participants with BP control

    Baseline, 6 months

  • Medication intensification when BP is uncontrolled

    Baseline, 6 months

  • Patient-reported medication adherence

    Baseline, 6 months

Study Arms (4)

Standard and One-time Training

ACTIVE COMPARATOR

Patient level: Standard, automatic reminders Clinic level: One-time training

Behavioral: Standard and One-time Training

Standard and Practice Facilitation

EXPERIMENTAL

Patient level: Standard, automatic reminders Clinic level: Regular, ongoing coaching

Behavioral: Standard and Practice Facilitation

High-intensity and One-time Training

EXPERIMENTAL

Patient level: Personalized feedback Clinic level: One-time training

Behavioral: High-intensity and One-time Training

High-intensity and Practice Facilitation

EXPERIMENTAL

Patient level: Personalized feedback Clinic level: Regular, ongoing coaching

Behavioral: High-intensity and Practice Facilitation

Interventions

Patient-level intervention: Patients in the standard group will receive automated reminder SMS text messages and remote BP monitoring. Clinic-level intervention: Clinics in the one-time training group will receive one-time training on standard work and algorithms, audit and feedback, and panel-based outreach.

Standard and One-time Training

Patient-level intervention: Patients in the standard group will receive automated reminder SMS text messages and remote BP monitoring. Clinic-level intervention: Clinics in the practice facilitation group will receive regular/ongoing training on standard work and algorithms, audit and feedback, and panel-based outreach.

Standard and Practice Facilitation

Patient-level intervention: Patients in the high-intensity group will receive personalized feedback SMS text messages and remote BP monitoring. Clinic-level intervention: Clinics in the one-time training group will receive one-time training on standard work and algorithms, audit and feedback, and panel-based outreach.

High-intensity and One-time Training

Patient-level intervention: Patients in the high-intensity group will receive personalized feedback SMS text messages and remote BP monitoring. Clinic-level intervention: Clinics in the practice facilitation group will receive regular/ongoing training on standard work and algorithms, audit and feedback, and panel-based outreach.

High-intensity and Practice Facilitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • Any sex/gender
  • Any race or ethnicity
  • Have hypertension or high blood pressure (BP) (BP \>=140/90 mmHg at least twice in the previous 18 months)
  • Can read and write English or Spanish
  • Be able to provide consent

You may not qualify if:

  • We will exclude individuals with conditions that might have severe self-management limitations due to a disability or medical condition or might complicate remote BP monitoring, such as self-reported:
  • Pregnancy
  • Lactating/nursing
  • Dialysis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zuckerberg San Francisco General Hospital

San Francisco, California, 94110, United States

Location

Related Publications (2)

  • Tieu L, Khoong EC, Shah ND, Gosdin MM, Wang SJ, Sharma A, Abtahi N, Stern RJ, Zhou C, Sarkar U, Lyles CR; CHARMED Consortium. Applying behavior change theory to intervention design: promoting clinic-level implementation of self-measured blood pressure monitoring in safety net primary care settings. Transl Behav Med. 2026 Jan 7;16(1):ibaf094. doi: 10.1093/tbm/ibaf094.

  • Lyles CR, Khoong EC, Stern RJ, Abtahi N, Sharma AE, Pletcher MJ, Xia F, Garcia F, Shah ND, Tieu L, Sarkar U; CHARMED consortium. Championing Hypertension Remote Monitoring for Equity and Dissemination (CHARMED): A multi-site factorial randomized controlled trial protocol. Contemp Clin Trials. 2025 May;152:107879. doi: 10.1016/j.cct.2025.107879. Epub 2025 Mar 12.

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Urmimala Sarkar

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 27, 2023

First Posted

November 2, 2023

Study Start

October 21, 2024

Primary Completion (Estimated)

April 1, 2028

Study Completion (Estimated)

July 1, 2028

Last Updated

January 23, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations